Does LARONIDASE Cause Poor venous access? 86 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 86 reports of Poor venous access have been filed in association with LARONIDASE (ALDURAZYME). This represents 2.8% of all adverse event reports for LARONIDASE.
86
Reports of Poor venous access with LARONIDASE
2.8%
of all LARONIDASE reports
5
Deaths
23
Hospitalizations
How Dangerous Is Poor venous access From LARONIDASE?
Of the 86 reports, 5 (5.8%) resulted in death, 23 (26.7%) required hospitalization.
Is Poor venous access Listed in the Official Label?
Yes, Poor venous access is listed as a known adverse reaction in the official FDA drug label for LARONIDASE.
What Other Side Effects Does LARONIDASE Cause?
Pyrexia (423)
Malaise (169)
Pneumonia (162)
Dyspnoea (157)
Vomiting (157)
Cough (154)
Fatigue (137)
Influenza (108)
Pain (107)
Inappropriate schedule of product administration (106)
What Other Drugs Cause Poor venous access?
VEDOLIZUMAB (1,043)
INFLIXIMAB (917)
INFLIXIMAB-DYYB (782)
ECULIZUMAB (555)
HUMAN IMMUNOGLOBULIN G (504)
NATALIZUMAB (422)
RITUXIMAB (299)
TOCILIZUMAB (287)
METHOTREXATE (257)
ABATACEPT (249)
Which LARONIDASE Alternatives Have Lower Poor venous access Risk?
LARONIDASE vs LAROTRECTINIB
LARONIDASE vs LASILIX
LARONIDASE vs LASIX
LARONIDASE vs LASMIDITAN
LARONIDASE vs LATANOPROST